Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;55(12):3328-35.
doi: 10.1007/s10620-010-1413-0. Epub 2010 Oct 7.

Occult hepatitis B: clinical implications and treatment decisions

Paul Schmeltzer  1 , Kenneth E Sherman
Affiliations
Review

Occult hepatitis B: clinical implications and treatment decisions

Paul Schmeltzer et al. Dig Dis Sci. 2010 Dec.

Abstract

First reported in 1978, occult hepatitis B is a term used to describe the presence of hepatitis B virus (HBV) DNA without hepatitis B surface antigenemia. The prevalence of occult HBV is unclear and depends in part on the sensitivity of the hepatitis B surface antigen (HBsAg) and DNA assays used as well as the prevalence of HBV infection in the study population. The origin of occult HBV also remains in question. Several mechanisms have been hypothesized including mutations in the regulatory regions of the HBV genome, persistence of Ig-bound HBV immune complexes, viral interference, and blockage of free HBsAg secretion. Occult HBV has important clinical implications such as transmission through blood transfusion, reactivation in the setting of immunosuppression, and interference with hepatitis C treatment. To date, there is little data pertaining to the treatment of occult HBV outside of the setting of chemotherapy-induced HBV reactivation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
See this image and copyright information in PMC

References

    1. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: Experimental findings and clinical implications. World J Gastroenterol. 2007;13(43):5682–5686. - PMC - PubMed
    1. Allain JP. Occult hepatitis B virus infection. Transfusion Clinique et Biologique. 2004;11:18–25. - PubMed
    1. Hoofnagle JH, Seef LB, Bales ZB, Zimmerman HJ. The type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 1978;298:1379–83. - PubMed
    1. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988;2:1273–76. - PubMed
    1. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. New England Journal of Medicine. 1999;341:22–26. - PubMed

Publication types